首页> 美国卫生研究院文献>World Journal of Clinical Cases >Successful recanalization with multimodality endovascular interventional therapy in acute ischemic stroke
【2h】

Successful recanalization with multimodality endovascular interventional therapy in acute ischemic stroke

机译:急性缺血性卒中的多模式血管内介入治疗成功实现再通

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Stroke is an important cause of death and disability in adults. However, effective treatments for patients with acute ischemic stroke are limited. Intravenous recombinant tissue plasminogen activator (iv rtPA) within 4.5 h after onset has been approved as a standard treatment for patients with acute ischemic stroke. However, due to time constraints, less than one percent of acute ischemic stroke patients in Thailand are able to obtain iv rtPA. Although endovascular interventional therapy has not yet been approved as standard treatment in acute ischemic stroke, it is the one of the potentially effective treatment options. There are several reliable methods of endovascular therapy for acute ischemic stroke patients. Endovascular interventional therapy has rarely been done in Thailand. We report seven patients with successful recanalization after endovascular treatment in acute large vessel stroke from a single stroke center in Thailand. Patient screening and selection with multimodal imaging protocol and multimodality methods of endovascular interventional therapy are described.
机译:中风是成年人死亡和残疾的重要原因。但是,对于急性缺血性中风患者的有效治疗是有限的。发病后4.5小时内静脉内重组组织纤溶酶原激活剂(iv rtPA)已被批准作为急性缺血性中风患者的标准治疗方法。但是,由于时间限制,在泰国,只有不到百分之一的急性缺血性中风患者能够获得静脉rtPA。尽管血管内介入治疗尚未被批准为急性缺血性中风的标准治疗方法,但它是潜在有效的治疗选择之一。对于急性缺血性中风患者,有几种可靠的血管内治疗方法。在泰国很少进行血管内介入治疗。我们报告了来自泰国的单个卒中中心的7例急性大血管卒中的血管内治疗后患者成功进行了再通。描述了使用多模式成像方案和血管内介入治疗的多模式方法对患者进行筛选和选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号